Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abatement, absolute, accident, AMP, androstenedione, begun, bloodstream, bundled, citizenship, confirmatory, Connecticut, constraint, construction, COSO, cyber, cyberattack, decree, demolition, depiction, dextrose, digital, effectuated, encryption, engineering, Eye, faithful, forensic, fulfilled, genotoxicity, glycemic, hacking, headcount, HHS, hundred, hydroxyprogesterone, Inflationary, input, inquiring, Intelligence, investee, IRA, landlord, malware, misregulated, misuse, month, NCCN, neurodevelopmental, NIDDK, NIH, nongovernmental, obfuscate, occupancy, opposed, outpace, Passport, pattern, PBH, penetration, phishing, phototoxicity, predetermined, predominately, proceed, proportionally, ransomware, ratably, recovery, recurrent, resurgence, safeguard, Secretary, standalone, stratified, stratum, sublease, theft, unfriendly, uniformly, Unitary, unqualified, UPC, Utah, vendor
Removed:
aimed, alleviate, assembled, attestation, Bellina, biometric, conversion, document, electrical, emerging, entitlement, exemption, filer, fine, fixed, Frank, GMP, golden, IPO, irrevocably, Jaffray, Jordan, lawfully, lessor, line, McLinn, modest, Mongiello, Morgan, nonbinding, parachute, Piper, revised, rotation, seasoned, stronger, supplemental, telecommunication, Trickett, trunk, undertaken, unfair, Wendler
Filing tables
Filing exhibits
Related press release
CRNX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Crinetics Pharmaceuticals, Inc.
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-258694) and Form S-8 (Nos. 333-226234, 333-254883, 333-264005 and 333-268328) of Crinetics Pharmaceuticals, Inc. of our reports dated February 28, 2023, relating to the consolidated financial statements and the effectiveness of Crinetics Pharmaceuticals, Inc.’s internal control over financial reporting, which appear in this Annual Report on Form 10-K.
/s/ BDO USA, LLP
San Diego, California
February 28, 2023